Antonio Munafò

810 total citations
22 papers, 579 citations indexed

About

Antonio Munafò is a scholar working on Physiology, Neurology and Infectious Diseases. According to data from OpenAlex, Antonio Munafò has authored 22 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 7 papers in Neurology and 6 papers in Infectious Diseases. Recurrent topics in Antonio Munafò's work include Alzheimer's disease research and treatments (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers) and Tryptophan and brain disorders (5 papers). Antonio Munafò is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers) and Tryptophan and brain disorders (5 papers). Antonio Munafò collaborates with scholars based in Italy, Germany and United Kingdom. Antonio Munafò's co-authors include Renato Bernardini, Giuseppina Cantarella, Chiara Burgaletto, Giulia Di Benedetto, Filippo Caraci, Rosaria Di Mauro, Agata Copani, Ferdinando Nicoletti, Gian Marco Leggio and Maria Angela Sortino and has published in prestigious journals such as International Journal of Molecular Sciences, Cell Death and Disease and Ageing Research Reviews.

In The Last Decade

Antonio Munafò

22 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Munafò Italy 11 208 161 141 133 74 22 579
Hung-Ming Wu Taiwan 12 88 0.4× 135 0.8× 141 1.0× 90 0.7× 37 0.5× 16 578
Massimo Barbierato Italy 17 125 0.6× 170 1.1× 211 1.5× 73 0.5× 104 1.4× 28 714
Ali K. Albuhadily Iraq 16 189 0.9× 183 1.1× 80 0.6× 53 0.4× 70 0.9× 58 630
Eduardo Duarte-Silva Brazil 14 116 0.6× 213 1.3× 61 0.4× 112 0.8× 49 0.7× 24 499
Dan Cheng China 13 80 0.4× 185 1.1× 75 0.5× 105 0.8× 69 0.9× 27 502
Soraya Wilke Saliba Germany 13 116 0.6× 199 1.2× 229 1.6× 113 0.8× 95 1.3× 22 629
Priya Mishra United States 8 100 0.5× 158 1.0× 197 1.4× 45 0.3× 52 0.7× 12 678
Li Hu China 16 274 1.3× 667 4.1× 93 0.7× 136 1.0× 50 0.7× 42 1.0k
Jessica Lynch United States 13 299 1.4× 210 1.3× 258 1.8× 67 0.5× 35 0.5× 25 791
Weihua Shao China 18 194 0.9× 362 2.2× 77 0.5× 251 1.9× 31 0.4× 33 748

Countries citing papers authored by Antonio Munafò

Since Specialization
Citations

This map shows the geographic impact of Antonio Munafò's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Munafò with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Munafò more than expected).

Fields of papers citing papers by Antonio Munafò

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Munafò. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Munafò. The network helps show where Antonio Munafò may publish in the future.

Co-authorship network of co-authors of Antonio Munafò

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Munafò. A scholar is included among the top collaborators of Antonio Munafò based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Munafò. Antonio Munafò is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Munafò, Antonio, Francesco De Cesaris, Claudia Altamura, et al.. (2025). Pharmacological differences and switching among anti‐ CGRP monoclonal antibodies: A narrative review. Headache The Journal of Head and Face Pain. 65(2). 342–352. 7 indexed citations
2.
Munafò, Antonio, Filippo Caraci, Enzo Emanuele, et al.. (2025). Gut microbiota in Alzheimer’s disease: Understanding molecular pathways and potential therapeutic perspectives. Ageing Research Reviews. 104. 102659–102659. 8 indexed citations
3.
Burgaletto, Chiara, Giulia Di Benedetto, Anna Pannaccione, et al.. (2024). Taming Microglia in Alzheimer’s Disease: Exploring Potential Implications of Choline Alphoscerate via α7 nAChR Modulation. Cells. 13(4). 309–309. 10 indexed citations
4.
Munafò, Antonio, Giulia Di Benedetto, Sebastiano Alfio Torrisi, et al.. (2024). Pharmacological enhancement of cholinergic neurotransmission alleviates neuroinflammation and improves functional outcomes in a triple transgenic mouse model of Alzheimer’s disease. Frontiers in Pharmacology. 15. 1386224–1386224. 8 indexed citations
5.
Munafò, Antonio, Davide Arillotta, Guido Mannaioni, et al.. (2022). Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?. Pharmaceuticals. 16(1). 68–68. 11 indexed citations
6.
Marıno, Andrea, Antonio Munafò, Manuela Ceccarelli, et al.. (2022). Ampicillin plus ceftriaxone therapy against Enterococcus faecalis endocarditis: A case report, guidelines considerations, and literature review. IDCases. 28. e01462–e01462. 6 indexed citations
7.
Marıno, Andrea, Antonio Munafò, Manuela Ceccarelli, et al.. (2022). Sarilumab Administration in COVID-19 Patients: Literature Review and Considerations. Infectious Disease Reports. 14(3). 360–371. 23 indexed citations
8.
Benedetto, Giulia Di, Chiara Burgaletto, Maria Francesca Serapide, et al.. (2022). TRAIL-R Deficient Mice Are Protected from Neurotoxic Effects of Amyloid-β. International Journal of Molecular Sciences. 23(19). 11625–11625. 8 indexed citations
9.
Marıno, Andrea, Stefano Stracquadanio, Antonio Munafò, et al.. (2022). Intravenous Fosfomycin: A Potential Good Partner for Cefiderocol. Clinical Experience and Considerations. Antibiotics. 12(1). 49–49. 21 indexed citations
10.
Benedetto, Giulia Di, et al.. (2022). Role of Microglia and Astrocytes in Alzheimer’s Disease: From Neuroinflammation to Ca2+ Homeostasis Dysregulation. Cells. 11(17). 2728–2728. 103 indexed citations
11.
Burgaletto, Chiara, Oronzo Brunetti, Antonio Munafò, et al.. (2021). Lights and Shadows on Managing Immune Checkpoint Inhibitors in Oncology during the COVID-19 Era. Cancers. 13(8). 1906–1906. 5 indexed citations
12.
Burgaletto, Chiara, Chiara Bianca Maria Platania, Giulia Di Benedetto, et al.. (2021). Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer’s disease. Cell Death and Disease. 12(10). 905–905. 29 indexed citations
13.
Bonaventura, Gabriele, Antonio Munafò, Valentina La Cognata, et al.. (2021). Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases?. Cells. 10(8). 1992–1992. 28 indexed citations
14.
Burgaletto, Chiara, Giulia Di Benedetto, Antonio Munafò, Renato Bernardini, & Giuseppina Cantarella. (2021). Beneficial Effects of Choline Alphoscerate on Amyloid-β Neurotoxicity in an In vitro Model of Alzheimer’s Disease. Current Alzheimer Research. 18(4). 298–309. 7 indexed citations
15.
Marıno, Andrea, Antonio Munafò, Manuela Ceccarelli, et al.. (2021). Ampicillin Plus Ceftriaxone Regimen against Enterococcus faecalis Endocarditis: A Literature Review. Journal of Clinical Medicine. 10(19). 4594–4594. 23 indexed citations
16.
Silvestris, Nicola, et al.. (2020). On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and Antineoplastic Agents. Frontiers in Oncology. 10. 1340–1340. 4 indexed citations
17.
Burgaletto, Chiara, Antonio Munafò, Giulia Di Benedetto, et al.. (2020). The immune system on the TRAIL of Alzheimer’s disease. Journal of Neuroinflammation. 17(1). 298–298. 63 indexed citations
18.
Munafò, Antonio, Chiara Burgaletto, Giulia Di Benedetto, et al.. (2020). Repositioning of Immunomodulators: A Ray of Hope for Alzheimer’s Disease?. Frontiers in Neuroscience. 14. 614643–614643. 21 indexed citations
19.
Caraci, Filippo, Simona Federica Spampinato, Maria Grazia Morgese, et al.. (2018). Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological target. Pharmacological Research. 130. 374–384. 132 indexed citations
20.
Caraci, Filippo, Fabio Tascedda, Sara Merlo, et al.. (2016). Fluoxetine Prevents Aβ1-42-Induced Toxicity via a Paracrine Signaling Mediated by Transforming-Growth-Factor-β1. Frontiers in Pharmacology. 7. 389–389. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hung-Ming Wu Breakdown of academic impact, for papers by Massimo Barbierato Breakdown of academic impact, for papers by Ali K. Albuhadily Breakdown of academic impact, for papers by Eduardo Duarte-Silva Breakdown of academic impact, for papers by Dan Cheng Breakdown of academic impact, for papers by Soraya Wilke Saliba Breakdown of academic impact, for papers by Priya Mishra Breakdown of academic impact, for papers by Li Hu Breakdown of academic impact, for papers by Jessica Lynch Breakdown of academic impact, for papers by Weihua Shao
Rankless by CCL
2026